Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2001 Nov-Dec;7(6):945–951. doi: 10.3201/eid0706.010605

Advanced age a risk factor for illness temporally associated with yellow fever vaccination.

M Martin 1, L H Weld 1, T F Tsai 1, G T Mootrey 1, R T Chen 1, M Niu 1, M S Cetron 1; GeoSentinel Yellow Fever Working Group1
PMCID: PMC2631902  PMID: 11747720

Abstract

In 1998, the Centers for Disease Control and Prevention was notified of severe illnesses and one death, temporally associated with yellow fever (YF) vaccination, in two elderly U.S. residents. Because the cases were unusual and adverse events following YF vaccination had not been studied, we estimated age-related reporting rates for systemic illness following YF vaccination. We found that the rate of reported adverse events among elderly vaccinees was higher than among vaccinees 25 to 44 years of age. We also found two additional deaths among elderly YF vaccinees. These data signal a potential problem but are not sufficient to reliably estimate incidence rates or to understand potential underlying mechanisms; therefore, enhanced surveillance is needed. YF remains an important cause of severe illness and death, and travel to disease-endemic regions is increasing. For elderly travelers, the risk for severe illness and death due to YF infection should be balanced against the risk for systemic illness due to YF vaccine.

Full Text

The Full Text of this article is available as a PDF (69.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barros M. L., Boecken G. Jungle yellow fever in the central Amazon. Lancet. 1996 Oct 5;348(9032):969–970. doi: 10.1016/s0140-6736(05)65392-5. [DOI] [PubMed] [Google Scholar]
  2. Centers for Disease Control and Prevention (CDC) Fatal yellow fever in a traveler returning from Venezuela, 1999. MMWR Morb Mortal Wkly Rep. 2000 Apr 14;49(14):303–305. [PubMed] [Google Scholar]
  3. Centers for Disease Control and Prevention (CDC) Fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination, 1996-2001. MMWR Morb Mortal Wkly Rep. 2001 Aug 3;50(30):643–645. [PubMed] [Google Scholar]
  4. Centers for Disease Control and Prevention (CDC) Outbreak of West Nile-like viral encephalitis--New York, 1999. MMWR Morb Mortal Wkly Rep. 1999 Oct 1;48(38):845–849. [PubMed] [Google Scholar]
  5. Chan R. C., Penney D. J., Little D., Carter I. W., Roberts J. A., Rawlinson W. D. Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet. 2001 Jul 14;358(9276):121–122. doi: 10.1016/S0140-6736(01)05341-7. [DOI] [PubMed] [Google Scholar]
  6. Chen R. T., Rastogi S. C., Mullen J. R., Hayes S. W., Cochi S. L., Donlon J. A., Wassilak S. G. The Vaccine Adverse Event Reporting System (VAERS). Vaccine. 1994 May;12(6):542–550. doi: 10.1016/0264-410x(94)90315-8. [DOI] [PubMed] [Google Scholar]
  7. Drouet A., Chagnon A., Valance J., Carli P., Muzellec Y., Paris J. F. Méningo-encéphalite après vaccination anti-amarile par la souche 17 D: deux observations. Rev Med Interne. 1993 Apr;14(4):257–259. doi: 10.1016/s0248-8663(05)82493-2. [DOI] [PubMed] [Google Scholar]
  8. EKLUND C. M. Encefalitis infantil en Costa Rica y Honduras después del empleo de la vacuna Dakar contra la fiebre amarilla. Bol Oficina Sanit Panam. 1953 Nov;35(5):505–516. [PubMed] [Google Scholar]
  9. Freedman D. O., Kozarsky P. E., Weld L. H., Cetron M. S. GeoSentinel: the global emerging infections sentinel network of the International Society of Travel Medicine. J Travel Med. 1999 Jun;6(2):94–98. doi: 10.1111/j.1708-8305.1999.tb00839.x. [DOI] [PubMed] [Google Scholar]
  10. Kelso J. M., Mootrey G. T., Tsai T. F. Anaphylaxis from yellow fever vaccine. J Allergy Clin Immunol. 1999 Apr;103(4):698–701. doi: 10.1016/s0091-6749(99)70245-9. [DOI] [PubMed] [Google Scholar]
  11. Martin M., Tsai T. F., Cropp B., Chang G. J., Holmes D. A., Tseng J., Shieh W., Zaki S. R., Al-Sanouri I., Cutrona A. F. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet. 2001 Jul 14;358(9276):98–104. doi: 10.1016/s0140-6736(01)05327-2. [DOI] [PubMed] [Google Scholar]
  12. McFarland J. M., Baddour L. M., Nelson J. E., Elkins S. K., Craven R. B., Cropp B. C., Chang G. J., Grindstaff A. D., Craig A. S., Smith R. J. Imported yellow fever in a United States citizen. Clin Infect Dis. 1997 Nov;25(5):1143–1147. doi: 10.1086/516111. [DOI] [PubMed] [Google Scholar]
  13. Merlo C., Steffen R., Landis T., Tsai T., Karabatsos N. Possible association of encephalitis and 17D yellow fever vaccination in a 29-year-old traveller. Vaccine. 1993;11(6):691–691. doi: 10.1016/0264-410x(93)90329-v. [DOI] [PubMed] [Google Scholar]
  14. Poland J. D., Calisher C. H., Monath T. P., Downs W. G., Murphy K. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ. 1981;59(6):895–900. [PMC free article] [PubMed] [Google Scholar]
  15. Prevots D. R., Sutter R. W., Strebel P. M., Weibel R. E., Cochi S. L. Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med. 1994 May;148(5):479–485. doi: 10.1001/archpedi.1994.02170050037007. [DOI] [PubMed] [Google Scholar]
  16. Robertson S. E., Hull B. P., Tomori O., Bele O., LeDuc J. W., Esteves K. Yellow fever: a decade of reemergence. JAMA. 1996 Oct 9;276(14):1157–1162. [PubMed] [Google Scholar]
  17. Rosenthal S., Chen R. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health. 1995 Dec;85(12):1706–1709. doi: 10.2105/ajph.85.12.1706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ryman K. D., Xie H., Ledger T. N., Campbell G. A., Barrett A. D. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice. Virology. 1997 Apr 14;230(2):376–380. doi: 10.1006/viro.1997.8496. [DOI] [PubMed] [Google Scholar]
  19. STONES P. B., MACNAMARA F. N. Encephalitis following neurotropic yellow fever vaccine administered by scarification in Nigeria: epidemiological and laboratory studies. Trans R Soc Trop Med Hyg. 1955 Mar;49(2):176–186. doi: 10.1016/0035-9203(55)90044-4. [DOI] [PubMed] [Google Scholar]
  20. Strebel P. M., Sutter R. W., Cochi S. L., Biellik R. J., Brink E. W., Kew O. M., Pallansch M. A., Orenstein W. A., Hinman A. R. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis. 1992 Feb;14(2):568–579. doi: 10.1093/clinids/14.2.568. [DOI] [PubMed] [Google Scholar]
  21. Teichmann D., Grobusch M. P., Wesselmann H., Temmesfeld-Wollbrück B., Breuer T., Dietel M., Emmerich P., Schmitz H., Suttorp N. A haemorrhagic fever from the Côte d'Ivoire. Lancet. 1999 Nov 6;354(9190):1608–1608. doi: 10.1016/s0140-6736(99)09233-8. [DOI] [PubMed] [Google Scholar]
  22. Theiler M., Smith H. H. THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION. J Exp Med. 1937 May 31;65(6):787–800. doi: 10.1084/jem.65.6.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tsai T. F., Popovici F., Cernescu C., Campbell G. L., Nedelcu N. I. West Nile encephalitis epidemic in southeastern Romania. Lancet. 1998 Sep 5;352(9130):767–771. doi: 10.1016/s0140-6736(98)03538-7. [DOI] [PubMed] [Google Scholar]
  24. Van der Stuyft P., Gianella A., Pirard M., Cespedes J., Lora J., Peredo C., Pelegrino J. L., Vorndam V., Boelaert M. Urbanisation of yellow fever in Santa Cruz, Bolivia. Lancet. 1999 May 8;353(9164):1558–1562. doi: 10.1016/s0140-6736(99)03291-2. [DOI] [PubMed] [Google Scholar]
  25. Vasconcelos P. F., Luna E. J., Galler R., Silva L. J., Coimbra T. L., Barros V. L., Monath T. P., Rodigues S. G., Laval C., Costa Z. G. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. Lancet. 2001 Jul 14;358(9276):91–97. doi: 10.1016/s0140-6736(01)05326-0. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES